Evidence map›Paper›PMID 32280582›Full record

ArticleRespiratory medicine case reports2020

Bilateral endobronchial metastases from prostate cancer: A case report with literature review.

Caibao Jin, Hui Ren, Yang Hu, Jingyi Wu, Yanping Hu, Zhijun Wang, Youying Wei, Bin Yang, Ling Yang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Caibao JinDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Hui RenDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Yang HuDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Jingyi WuDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Yanping HuDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Zhijun WangDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Youying WeiDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Bin YangDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.
Ling YangDepartment of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endobronchial metastases from prostate cancers are a rare phenomenon with only limited cases reported to date. Bronchoscopic biopsy and immunohistochemical test are essential for determining the diagnosis. And serum PSA level is a significant biomarker to assist the diagnosis. Our case describes a 68-year-old man presenting with bilateral endobronchial metastases after 5 years disease-free survival of prostate cancer.

Indexed as

Endobronchial metastasesHormonal therapyProstate cancer

Identifiers

PMID32280582
PMCPMC7139149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.